Immunomodulation by theophylline in asthma: Demonstration by withdrawal of therapy

American Journal of Respiratory and Critical Care Medicine

Volumn 151, Issue 6, 1995, Pages 1907-1914

  Kidney, Joseph ^b   Dominguez, Martin ^b   Taylor, Patricia M ^b   Rose, Marlene ^b   Chung, K Fan ^b   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; PLACEBO; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHUS BIOPSY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SMOOTH MUSCLE; T LYMPHOCYTE ACTIVATION;

EID: 0029050605     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.151.6.7767539     Document Type: Article

References (39)

1. Barnes P. J. 1989. A new approach to the treatment of asthma therapy. N. Engl. J. Med. 321:1517-1527.
2. Guillot C., M. Fornaris, M. Badier, and J. Orehek. 1984. Spontaneous and provoked resistance to isoproterenol in isolated human bronchi. J. Allergy Clin. Immunol. 74:713-718.
3. National Heart Lung and Blood Institute. 1991. National asthma education program expert panel report: guidelines for the diagnosis and management of asthma. J. Allergy Clin. Immunol. 88:425-534.
4. Pauwels, R., D. van Revterghem, M. van der Straeten, N. Johansson, and C. G. A. Persson. 1985. The effect of theophylline and enprophylline on allergen-induced bronchoconstriction. J. Allergy Clin. Immunol. 76:583-590.
5. Crescioli, S., A. Spinazzi, M. Plebani, M. Pozzani, C. E. Napp, P. Boschetto, and L. M. Fabbri. 1991. Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. Ann. Allergy 66:245-251.
6. Ward, A. J. M., M. G. McKenniff, J. M. Evans, C. P. Page, and J. F. Costello. 1993. Theophylline - an immunomodulatory role in asthma? Am. Rev. Respir. Dis. 147:518-523.
7. O'Byrne, P. M., F. E. Hargreave, and J. G. Kirby. 1987. Late asthmatic responses. Am. Rev. Respir. Dis. 136:740-751.
8. De Monchy, J. G. R., H. P. Kauffman, P. Venge, G. H. Koëter, H. M. Jansen, H. J. Sluiter, and K. deVries. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373-376.
9. Yukawa, T., C. Kroegel, G. Dent, P. Chanez, D. Ukena, K. F. Chung, and P. J. Barnes. 1989. Effect of theophylline and adenosine on eosinophil function. Am. Rev. Respir. Dis. 140:327-333.
10. Kay, A. B. 1991. Asthma and inflammation. J. Allergy Clin. Immunol. 87:893-910.
11. Limatibul, S., A. Shore, H. M. Dorsch, and E. Gelfand. 1978. Theophylline modulation of E-rosette formation: an indicator of T cell maturation. Clin. Exp. Immunol. 33:503-513.
12. Bruserud, O. 1984. The effect of theophyllamine on T-lymphocyte activation in vitro. Clin. Immunol. Immunopathol. 32:111-118.
13. Mary D., C. Aussel, B. Ferrua, and M. Fehlmann. 1987. Regulation of interleukin 2 synthesis by cAMP in human T cells. J. Immunol. 139:1179-1184.
14. Fink, G., M. Mittelman, B. Shohat, and S. A. Spitzer. 1987. Theophylline-induced alterations in cellular immunity in asthmatic patients. Clin. Allergy 17:313-316.
15. Scordamalglia, A., G. Ciprandi, S. Ruffoni, M. Caria, F. Paolieri, D. Venuti, and G. W. Canonica. 1988. Theophylline and the immune response: in vitro and in vivo effects. Clin. Immunol. Immunopathol. 48:238-246.
16. Shohat, B., B. Volovitz, and I. Varsano. 1983. Induction of suppressor T cells in asthmatic children by theophylline treatment. Clin. Allergy 13:487-493.
17. Pardi, R., M. Zocchi, E. Ferrero, G. F. Ciboddo, L. Inverardi, and C. Rugarli. 1984. In vivo effects of a single infusion of theophylline on human peripheral blood lymphocytes. Clin. Exp. Immunol. 57:722-728.
18. Weinburger, M. 1984. The pharmacology and therapeutic use of theophylline. J. Allergy Clin. Immunol. 73:525-540.
19. Nassif, E. G., M. Weinburger, R. Thompson, and W. Huntley. 1981. The value of maintenance theophylline in steroid-dependent asthma. N. Engl. J. Med. 304:71-75.
20. Brenner, M. R., R. Berkowitz, N. Marshall, and R. C. Strunk. 1988. Need for theophylline in severe steroid-requiring asthmatics. Clin. Allergy 18:143-150.
21. Lam, A., and M. T. Newhouse. 1990. Management of asthma and chronic airflow limitation. Are methylxanthines obsolete? Chest 98:44-52.
22. American Thoracic Society. 1987. Chronic bronchitis, asthma and pulmonary emphysema. Am. Rev. Respir. Dis. 136:224-225.
23. Rowe D. J. F., I. D. Watson, J. Williams, and D. J. Berry. 1988. Clinical management of theophylline. Ann. Clin. Biochem. 25:4-26.
24. Chrystyn, H., J. W. Ellis, B. A. Mulley, and M. D. Peake. 1988. The accuracy and stability of Bayesian theophylline predictions. Therapeutic Drug Monitoring 10:299-305.
25. Barnes, P. J., A. P. Greening, L. Neville, J. Timmers, and G. W. Poole. 1982. Single dose slow-release aminophylline at night prevents nocturnal asthma. Lancet i:299-301.
26. Heins, M., L. Kurtin, M. Oellerich, R. Maes, and G. W. Sybrecht. 1988. Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy. Eur. Respir. J. 1:306-310.
27. Martin, R. J., and J. Pak. 1992. Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 145:540-544.
28. Walker, C., E. Bode, L. Buer, T. T. Hansel, K. Blaser, and J.-C. Virchow. 1992. Allergic and non allergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.
29. Tai, P. C., C. J. Spry, C. Peierson, P. Venge, and I. Olsson. 1984. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 309:182-184.
30. Gerblich, A. A., H. Salik, and M. R. Schuyler. 1991. Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen provocation. Am. Rev. Respir. Dis. 143:533-537.
31. Sullivan, P., S. Bekir, Z. Jaffar, C. Page, P. Jeffery, and J. Costello. 1994. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 343:1006-1008.
32. Wilson, J. W., R. Djukanovic, P. H. Howarth, and S. T. Holgate. 1994. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am. J. Respir. Crit. Care Med. 149:86-90.
33. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulo, J. Barkans, A. M. Bentley, C. J. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant Th2-type bronchoalveolar lavage T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
34. Bloom, B. R., P. Salgame, and B. Diamond. 1992. Revisiting and revising suppressor T cells. Immunology Today 13:131-136.
35. Robicsek, S., D. K. Blanchard, J. Ojeu, J. J. Krzanowski, A. Szentivanyi, and J. B. Polson. 1991. Multiple high affinity cAMP phosphodiesterases in human T-lymphocytes. Biochem. Pharmacol. 42:869-877.
36. Essayan, D.M., A. Kagey Sobotka, L.M. Lichtenstein, and S.R. Huang. 1993. Modulation of allergen-induced cytokine gene expression and proliferation by phosphodiesterase inhibitors in vivo. J. Allergy Clin. Immunol. 91:254.
37. Endres, S., H. I. Fulle, B. Sinha, D. Stoll, C. A. Dinarello, R. Gerger, and P. C. Weber. 1991. Cyclic nucleotides differentially regulate the synthesis of tumor necrosis factor-a and interleukin-1β by human mononuclear cells. Immunology 72:56-60.
38. Dent, G., M. A. Giembycz, K. F. Rabe, B. Wolf, P. J. Barnes, and H. Magnussen. 1994. Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition. Am. J. Respir. Cell Mol. Biol. 10:565-572.
39. Barnes, P. J., and R. A. Pauwels. 1994. Theophylline in asthma: time for reappraisal. Eur. Respir. J. 7:579-591.